Washington University researchers recently published a study in the New England Journal of Medicine reporting that it is often faster and more effective to sequence the genome of people with blood cancers than to order them traditional tests. Dr. Green says that the findings from this study are a start, but despite the tremendous enthusiasm around the use of DNA technologies in treating cancer, the uptake of these services has not matched the hype. He expresses that all doctors treating these type of cancers should start considering using genome sequencing now as it can be a potential game-changer.
